In this episode, we dive into a question-and-answer session offering clinical guidance on treating antimicrobial-resistant Gram-negative bacterial infections in the United States. Here’s what you’ll learn:
🦠 Pathogen-Specific Approaches: Treatment strategies for bacteria producing extended-spectrum β-lactamases (ESBLs), AmpC β-lactamases, carbapenem-resistant Enterobacterales (CRE), Acinetobacter baumannii, and difficult-to-treat Pseudomonas aeruginosa.
💊 Antibiotic Recommendations: Suggested adult dosages and the importance of optimizing regimens to combat resistance.
🔬 In Vitro Susceptibility Testing: Why testing is critical to selecting effective therapies.
⚖️ Combination Therapies: When and how to use combination antibiotic strategies for better outcomes.
📚 Data Gaps and Research Needs: Limitations of current knowledge and the necessity for ongoing research to improve treatment options.
This episode provides actionable guidance for healthcare professionals tackling the challenges of multidrug-resistant Gram-negative infections, equipping them with evidence-based approaches to improve patient outcomes. Tune in to stay updated on this critical topic!
